Shenzhen Kangtai Biological Products Co (SZSE:300601) Change In Receivables : ¥0 Mil (TTM As of Mar. 2024)

View and export this data going back to 2017. Start your Free Trial

What is Shenzhen Kangtai Biological Products Co Change In Receivables?

Shenzhen Kangtai Biological Products Co's change in receivables for the quarter that ended in Mar. 2024 was ¥0 Mil. It means Shenzhen Kangtai Biological Products Co's Accounts Receivable stayed the same from Dec. 2023 to Mar. 2024 .

Shenzhen Kangtai Biological Products Co's change in receivables for the fiscal year that ended in Dec. 2023 was ¥-417 Mil. It means Shenzhen Kangtai Biological Products Co's Accounts Receivable increased by ¥417 Mil from Dec. 2022 to Dec. 2023 .

Shenzhen Kangtai Biological Products Co's Accounts Receivable for the quarter that ended in Mar. 2024 was ¥2,716 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Shenzhen Kangtai Biological Products Co's Days Sales Outstanding for the three months ended in Mar. 2024 was 548.66.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Shenzhen Kangtai Biological Products Co's liquidation value for the three months ended in Mar. 2024 was ¥-1,918 Mil.

Shenzhen Kangtai Biological Products Co Change In Receivables Historical Data

The historical data trend for Shenzhen Kangtai Biological Products Co's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Shenzhen Kangtai Biological Products Co Change In Receivables Chart

Shenzhen Kangtai Biological Products Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-178.33

-796.49

273.88

-488.76

-417.18

Shenzhen Kangtai Biological Products Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Change In Receivables	Get a 7-Day Free Trial															-	-	-	-	-

Shenzhen Kangtai Biological Products Co Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥0 Mil.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Shenzhen Kangtai Biological Products Co's Days Sales Outstanding for the quarter that ended in Mar. 2024 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	2715.699	/	451.659	*	91
=	548.66

2. In Ben Graham's calculation of liquidation value, Shenzhen Kangtai Biological Products Co's accounts receivable are only considered to be worth 75% of book value:

Shenzhen Kangtai Biological Products Co's liquidation value for the quarter that ended in Mar. 2024 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	996.961	-	5399.303	+	0.75 * 2715.699	+	0.5 * 896.004
=	-1,918

Shenzhen Kangtai Biological Products Co Change In Receivables Related Terms

Thank you for viewing the detailed overview of Shenzhen Kangtai Biological Products Co's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Shenzhen Kangtai Biological Products Co (SZSE:300601) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Shenzhen Kangtai Biological Products Co Ltd (SZSE:300601) » Definitions » Change In Receivables

Traded in Other Exchanges

N/A

Address

No. 6 Kefa Road, Science and Technology Industrial Park, Nanshan District, Shenzhen, CHN, 518057

Website

http://www.biokangtai.com

Shenzhen Kangtai Biological Products Co Ltd is a human vaccine research and development company. The company is engaged in the research and development, production and sales of recombinant hepatitis B vaccine, b -type influenza Haemophilus conjugate vaccine, measles-rubella combined live attenuated vaccine, cell-free baibai broke b Haemophilus influenzae vaccine and other products.

Executives

Liu Jian Kai	Directors, executives
Tao Jin	Secretary Dong
Zheng Hai Fa	Directors, executives
Zhou Hui	Executives
Miao Xiang	Directors, executives
Wen Fei Dong	Director
Du Wei Min	Directors, executives
Lv Zhi Yun	Supervisors
Gan Jian Hui	Executives
Zhu Zheng Yu	Executives
Liu Qun	Executives
Li Tong	Executives
Yuan Li Ping	Director
Li Xiang Ming	Independent director

Shenzhen Kangtai Biological Products Co (SZSE:300601) Headlines

No Headlines